DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sevelamer
Sevelamer
Phosphate Binders
Bright Pleiotropic Properties in Renal Failure and Dialysis Patients
Efficacy and Safety of Sucroferric Oxyhydroxide Compared with Sevelamer
Aetna Formulary Exclusions Drug List
The Indirect Implication of SARS-Cov-2 Resulting in Kayexalate Toxicity in a Patient with Acute Kidney Injury
Estonian Statistics on Medicines 2016 1/41
Case Report Sevelamer Carbonate Crystal-Induced Colitis
Phosphate Binders As a Cause of Hypothyroidism in Dialysis Patients
205739Orig1s000
Clinical Rationale of Sucroferric Oxyhydroxide for Controlling
A New Medication for Fibromyalgia: Milnacipran
Switching from Allopurinol to Febuxostat: Efficacy and Tolerability in Hemodialysis Patients Satoru Mitsuboshi1*, Hitoshi Yamada1, Kazuhiko Nagai1 and Hideo Okajima2
205109S006lbl.Pdf
Estonian Statistics on Medicines 2013 1/44
BC BA HA Standard with Step Drug List July 2021
Sevelamer Carbonate 800 Mg Film-Coated Tablets Sevelamer Carbonate
List of Formulary Drug Removals
Renvela® Sevelamer Carbonate Consumer Medicine Information
Top View
Renagel, INN-Sevelamer
Australian Public Assessment Report for Sodium Zirconium Cyclosilicate Hydrate
Therapeutic Class Overview Electrolyte Depleters
Clinical Protocol ZS-004
Kidney News | December 2017
Tumor Lysis Syndrome and Hyperphosphatemia
Sevelamer Hydrochloride for the Treatment of Patients with Chronic Kidney Disease: a Review of the Clinical Effectiveness
Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
13.2 Part VI.2 Elements for a Public Summary
Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
Therapeutic Class Overview Electrolyte Depleters
Sevelamer (Renagel®)
Phosphate Binders (Non-Calcium, Non-Aluminum) Lanthanum Carbonate, Sevelamer Carbonate, Ferric Citrate, Sucroferric Oxyhydroxide
Sevelamer Carbonate Tablets (8-Week Cross-Over) Study Were: Nausea Renvela (Sevelamer Carbonate) Tablet, Film Coated for Oral Use (3%) and Vomiting (3%)
Prescription Drug Guide
Clinical Review Report for Sodium Zirconium Cyclosilicate (Lokelma) 2
1 Sucroferric Oxyhydroxide As Part of Combination Phosphate Binder
Evaluation of Carcinogenicity Studies of Medicinal Products for Human Use Authorised Via the European Centralised Procedure